Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026)

Regeneron Pharmaceuticals has reported Change in Inventory for 14 years, with the latest figure at -$26.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 117.47% year-over-year to -$26.6 million; the trailing twelve-month figure through Mar 2026 stood at $96.4 million (down 84.36% YoY), and the FY2025 full-year result was $275.3 million, down 55.58% from the prior year.
• Change in Inventory for Q1 2026 stood at -$26.6 million, down from -$2.1 million in the prior quarter.
• The five-year high for Change in Inventory was $240.1 million in Q2 2022, with the low at -$26.6 million in Q1 2026.
• Average Change in Inventory over 5 years is $108.0 million, with a median of $100.4 million recorded in 2023.
• Year-over-year, Change in Inventory surged 867.09% in 2022 and plunged 117.47% in 2026.
• Tracing REGN's Change in Inventory over 5 years: stood at $144.3 million in 2022, then slumped by 67.22% to $47.3 million in 2023, then surged by 148.84% to $117.7 million in 2024, then plunged by 101.78% to -$2.1 million in 2025, then sank by 1166.67% to -$26.6 million in 2026.
• The last three Change in Inventory figures came in at -$26.6 million (Q1 2026), -$2.1 million (Q4 2025), and $82.6 million (Q3 2025), per Business Quant data.

Peer Comparison